Your browser doesn't support javascript.
loading
Serine/threonine kinase inhibition as antifibrotic therapy: transforming growth factor-ß and Rho kinase inhibitors.
Mendoza, Fabian A; Jimenez, Sergio A.
Affiliation
  • Mendoza FA; Division of Rheumatology, Department of Medicine.
  • Jimenez SA; Jefferson Institute of Molecular Medicine and Scleroderma Center, Thomas Jefferson University, Philadelphia, PA, USA.
Rheumatology (Oxford) ; 61(4): 1354-1365, 2022 04 11.
Article in En | MEDLINE | ID: mdl-34664623
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transforming Growth Factor beta / Protein Serine-Threonine Kinases Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Transforming Growth Factor beta / Protein Serine-Threonine Kinases Limits: Humans Language: En Journal: Rheumatology (Oxford) Journal subject: REUMATOLOGIA Year: 2022 Document type: Article Country of publication: